相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
Hanwen Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Quantitative Systems Pharmacology Modeling of PBMC-Humanized Mouse to Facilitate Preclinical Immuno-oncology Drug Development
Huilin Ma et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Integration of Omics Data Sources to Inform Mechanistic Modeling of Immune-Oncology Therapies: A Tutorial for Clinical Pharmacologists
Georgia Lazarou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian et al.
SCIENCE (2020)
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
Hanwen Wang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk et al.
CANCER CELL (2020)
Hybrid Automata Library: A flexible platform for hybrid modeling with real-time visualization
Rafael R. Bravo et al.
PLoS Computational Biology (2020)
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Raju K. Vaddepally et al.
CANCERS (2020)
A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor
Huilin Ma et al.
AAPS JOURNAL (2020)
Deep learning-based image analysis methods for brightfield-acquired multiplex immunohistochemistry images
Danielle J. Fassler et al.
DIAGNOSTIC PATHOLOGY (2020)
The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung
Yoshinobu Ichiki et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
Haoyang Mi et al.
FRONTIERS IN PHYSIOLOGY (2020)
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model
Huilin Ma et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications
Richard J. Sove et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Digital pathology and artificial intelligence
Muhammad Khalid Khan Niazi et al.
LANCET ONCOLOGY (2019)
Intratumoral Heterogeneity: More Than Just Mutations
Kunihiko Hinohara et al.
TRENDS IN CELL BIOLOGY (2019)
In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model
Hanwen Wang et al.
ROYAL SOCIETY OPEN SCIENCE (2019)
Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices
Jane P. F. Bai et al.
AAPS JOURNAL (2019)
A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer
Mohammad Jafarnejad et al.
AAPS JOURNAL (2019)
A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade
Oleg Milberg et al.
SCIENTIFIC REPORTS (2019)
Quantitative Characterization of CD8+ T Cell Clustering and Spatial Heterogeneity in Solid Tumors
Chang Gong et al.
FRONTIERS IN ONCOLOGY (2019)
Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment
Kerri-Ann Norton et al.
PROCESSES (2019)
Quantitative Systems Pharmacology: An Exemplar Model-Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug Development
Gabriel Helmlinger et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Tumor Ensemble-Based Modeling and Visualization of Emergent Angiogenic Heterogeneity in Breast Cancer
Spyros K. Stamatelos et al.
SCIENTIFIC REPORTS (2019)
An Agent-based Model for Investigating the Effect of Myeloid-Derived Suppressor Cells and its Depletion on Tumor Immune Surveillance
Armin Allahverdy et al.
JOURNAL OF MEDICAL SIGNALS & SENSORS (2019)
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
Matthew D. Hellmann et al.
CANCER CELL (2018)
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer
Giovanna Armani et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Modeling triple-negative breast cancer heterogeneity: Effects of stromal macrophages, fibroblasts and tumor vasculature
Kerri-Ann Norton et al.
JOURNAL OF THEORETICAL BIOLOGY (2018)
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
Joel Saltz et al.
CELL REPORTS (2018)
PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems
Ahmadreza Ghaffarizadeh et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer
Sandrine Niyongere et al.
JOURNAL OF THORACIC DISEASE (2018)
Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems model
Yuri Kosinsky et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
Julie R. Brahmer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Emerging strategies for combination checkpoint modulators in cancer immunotherapy
Aleksandra Popovic et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Topography of cancer-associated immune cells in human solid tumors
Jakob Nikolas Kather et al.
ELIFE (2018)
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
Nicolas A. Giraldo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
Irene Moya-Horno et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Translating Mouse Models: Immune Variation and Efficacy Testing
Rani S. Sellers
TOXICOLOGIC PATHOLOGY (2017)
A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition
Chang Gong et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2017)
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
Christian Manegold et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
Sami Blom et al.
SCIENTIFIC REPORTS (2017)
In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer
Jakob Nikolas Kather et al.
CANCER RESEARCH (2017)
QSP Toolbox: Computational Implementation of Integrated Workflow Components for Deploying Multi-Scale Mechanistic Models
Yougan Cheng et al.
AAPS JOURNAL (2017)
BioFVM: an efficient, parallelized diffusive transport solver for 3-D biological simulations
Ahmadreza Ghaffarizadeh et al.
BIOINFORMATICS (2016)
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
Ashley Cimino-Mathews et al.
HUMAN PATHOLOGY (2016)
The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
Pankita H. Pandya et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
The promises of quantitative systems pharmacology modelling for drug development
V. R. Knight-Schrijver et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology
Andreas Heindl et al.
LABORATORY INVESTIGATION (2015)
Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer
Sidra Nawaz et al.
MODERN PATHOLOGY (2015)
Cancer and the Immune System: Basic Concepts and Targets for Intervention
Drew Pardoll
SEMINARS IN ONCOLOGY (2015)
FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?
M. C. Peterson et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location
Kerri-Ann Norton et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
A bioimage informatics based reconstruction of breast tumor microvasculature with computational blood flow predictions
Spyros K. Stamatelos et al.
MICROVASCULAR RESEARCH (2014)
Quantitative Systems Pharmacology can reduce attrition and improve productivity in pharmaceutical research and development
Tarek A. Leil et al.
FRONTIERS IN PHARMACOLOGY (2014)
Cellular Heterogeneity and Molecular Evolution in Cancer
Vanessa Almendro et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)
A Hybrid Cellular Automaton Model of Solid Tumor Growth and Bioreductive Drug Transport
Nabila Kazmi et al.
IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer model
Zhihui Wang et al.
BIOINFORMATICS (2009)
LibSBML: an API library for SBML
Benjamin J. Bornstein et al.
BIOINFORMATICS (2008)
The effects of EGF-receptor density on multiscale tumor growth patterns
CA Athale et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
The systems biology markup language (SBML):: a medium for representation and exchange of biochemical network models
M Hucka et al.
BIOINFORMATICS (2003)
分享论文
